Joan Brugge, Chair of the Department of Cell Biology at Harvard Medical School, said the new study "provides exciting new insights into yet another aspect of cell plasticity that was not appreciated previously and that offers great potential therapeutically. Direct reprogramming represents a more straight-forward strategy to treat diseases involving loss of function of specific cell populations than approaches requiring an intermediate embryonic stem cell," she said.